Cargando…

Probiotic VSL#3 Treatment Reduces Colonic Permeability and Abdominal Pain Symptoms in Patients With Irritable Bowel Syndrome

Background: Little is known regarding the clinical impact of treatment and treatment duration of probiotic VSL#3 on gut and microbiome function in irritable bowel syndrome (IBS). As part of a safety trial, we assessed the effect of VSL#3 treatment duration on abdominal pain, stooling, gut permeabili...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boonma, Prapaporn, Shapiro, Jordan M., Hollister, Emily B., Badu, Shyam, Wu, Qinglong, Weidler, Erica M., Abraham, Bincy P., Devaraj, Sridevi, Luna, Ruth Ann, Versalovic, James, Heitkemper, Margaret M., Savidge, Tor C., Shulman, Robert J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pain Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915646/ https://www.ncbi.nlm.nih.gov/pubmed/35295488 http://dx.doi.org/10.3389/fpain.2021.691689

Ejemplares similares

Donor-recipient specificity and age-dependency in fecal microbiota therapy and probiotic resolution of gastrointestinal symptoms
por: Wu, Qinglong, et al.
Publicado: (2023)

Leveraging Human Microbiome Features to Diagnose and Stratify Children with Irritable Bowel Syndrome
por: Hollister, Emily B., et al.
Publicado: (2019)

Chronic bacterial prostatitis and irritable bowel syndrome: effectiveness of treatment with rifaximin followed by the probiotic VSL#3
por: Vicari, Enzo, et al.
Publicado: (2014)

Probiotics VSL#3 Protect against Development of Visceral Pain in Murine Model of Irritable Bowel Syndrome
por: Distrutti, Eleonora, et al.
Publicado: (2013)

Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome
por: Labus, Jennifer S., et al.
Publicado: (2017)

Lactobacillus rhamnosus L34 and Lactobacillus casei L39 suppress Clostridium difficile-induced IL-8 production by colonic epithelial cells
por: Boonma, Prapaporn, et al.
Publicado: (2014)

The protective effect of VSL#3 on intestinal permeability in a rat model of alcoholic intestinal injury
por: Chang, Bing, et al.
Publicado: (2013)

Episodic Memories Among Irritable Bowel Syndrome (IBS) Patients: An Important Aspect of the IBS Symptom Experience
por: Sayuk, Gregory S., et al.
Publicado: (2022)

Comparative genomic analysis of the multispecies probiotic-marketed product VSL#3
por: Douillard, François P., et al.
Publicado: (2018)

Sex-Bias in Irritable Bowel Syndrome: Linking Steroids to the Gut-Brain Axis
por: So, Sik Yu, et al.
Publicado: (2021)

Importance of Non-pharmacological Approaches for Treating Irritable Bowel Syndrome: Mechanisms and Clinical Relevance
por: Orock, Albert, et al.
Publicado: (2021)

New Host-Directed Therapeutics for the Treatment of Clostridioides difficile Infection
por: Andersson, Jourdan A., et al.
Publicado: (2020)

Genomic Effects Associated With Response to Placebo Treatment in a Randomized Trial of Irritable Bowel Syndrome
por: Wang, Rui-Sheng, et al.
Publicado: (2022)

Probiotic Therapy With VSL#3(®) in Patients With NAFLD: A Randomized Clinical Trial
por: Derosa, Giuseppe, et al.
Publicado: (2022)

Neonatal Antibiotics Disrupt Motility and Enteric Neural Circuits in Mouse Colon
por: Hung, Lin Y., et al.
Publicado: (2019)

Correction: Comparative genomic analysis of the multispecies probiotic-marketed product VSL#3
por: Douillard, François P., et al.
Publicado: (2018)

Symptom Severity Following Rifaximin and the Probiotic VSL#3 in Patients with Chronic Pelvic Pain Syndrome (Due to Inflammatory Prostatitis) Plus Irritable Bowel Syndrome
por: Vicari, Enzo, et al.
Publicado: (2017)

Commentary: Adherence with a low-FODMAP diet in irritable bowel syndrome: are eating disorders the missing link?
por: Chumpitazi, Bruno P., et al.
Publicado: (2019)

Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases
por: Cheng, Fang-Shu, et al.
Publicado: (2020)

Draft genome sequences and description of Lactobacillus rhamnosus strains L31, L34, and L35
por: Boonma, Prapaporn, et al.
Publicado: (2014)

Amelioration of intestinal and systemic sequelae of murine Campylobacter jejuni infection by probiotic VSL#3 treatment
por: Ekmekciu, Ira, et al.
Publicado: (2017)

PReS-FINAL-2074: The role of the probiotic VSL-3 as adjuvant therapy in patients with undifferentiated spondyloarthritis (ERA)
por: Vidovic, M, et al.
Publicado: (2013)

Corrigendum to “Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases”
por: Sang, Li-Xuan
Publicado: (2021)

Probiotic colonization dynamics after oral consumption of VSL#3(®) by antibiotic-treated mice
por: Theriot, Casey, et al.
Publicado: (2022)

From Prediction to Function Using Evolutionary Genomics: Human-Specific Ecotypes of Lactobacillus reuteri Have Diverse Probiotic Functions
por: Spinler, Jennifer K., et al.
Publicado: (2014)

Randomized clinical trial of dexketoprofen/tramadol 25 mg/75 mg in moderate-to-severe pain after total hip arthroplasty
por: McQuay, H. J., et al.
Publicado: (2016)

Irritable bowel syndrome in midlife women: a narrative review
por: Yang, Pei-Lin, et al.
Publicado: (2021)

VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer
por: Arthur, Janelle C., et al.
Publicado: (2013)

Conditioned pain modulation identifies altered sensitivity in extremely preterm young adult males and females
por: Walker, S.M., et al.
Publicado: (2018)

Pain management after total knee arthroplasty: PROcedure SPEcific Postoperative Pain ManagemenT recommendations
por: Lavand’homme, Patricia M., et al.
Publicado: (2022)

Implementation of the quality management system improves postoperative pain treatment: a prospective pre-/post-interventional questionnaire study
por: Usichenko, T. I., et al.
Publicado: (2013)

Is number sense impaired in chronic pain patients?
por: Wolrich, J., et al.
Publicado: (2014)

Somatosensory function and pain in extremely preterm young adults from the UK EPICure cohort: sex-dependent differences and impact of neonatal surgery
por: Walker, S.M., et al.
Publicado: (2018)

Utility of unidimensional and functional pain assessment tools in adult postoperative patients: a systematic review()
por: Baamer, Reham M., et al.
Publicado: (2022)

Probiotics (VSL#3) Prevent Endothelial Dysfunction in Rats with Portal Hypertension: Role of the Angiotensin System
por: Rashid, Sherzad K., et al.
Publicado: (2014)

Alcohol Consumption in Relation to Risk and Severity of Chronic Widespread Pain: Results From a UK Population‐Based Study
por: Macfarlane, Gary J., et al.
Publicado: (2015)

Efficacy and safety of fasinumab in patients with chronic low back pain: a phase II/III randomised clinical trial
por: Dakin, Paula, et al.
Publicado: (2021)

Development of omics‐based protocols for the microbiological characterization of multi‐strain formulations marketed as probiotics: the case of VSL#3
por: Mora, Diego, et al.
Publicado: (2019)

Patient-reported improvements in health are maintained 2 years after completing a short course of cognitive behaviour therapy, exercise or both treatments for chronic widespread pain: long-term results from the MUSICIAN randomised controlled trial
por: Beasley, Marcus, et al.
Publicado: (2015)

THE EFFECT OF IRRITATION ON THE PERMEABILITY OF THE MENINGES FOR SALVARSAN
por: Stillman, Edgar, et al.
Publicado: (1915)

Cannot write session to /tmp/vufind_sessions/sess_4mg2p1pr75lvhb7g6j0mpopk4t